LONDON, June 9, 2016 /PRNewswire/ --
The essential components of comprehensive and long term care of spastic paresis are highlighted in an article published recently in European Neurological Review the peer-reviewed journal from touchNEUROLOGY. Anthony Ward et al, discussspastic paresis, a frequent complication of lesions to central motor pathways and approaches to managing the condition. Patients who develop spasticity require specialised rehabilitation programmes to alleviate their symptoms, help them to relearn motor skills and regain some independence. Long-term management of patients with spastic paresis requires a comprehensive approach that addresses the patient's physical needs and mental wellbeing, and continues throughout all stages of the rehabilitation process. There are three pillars of success for long-term rehabilitation programmes in spastic paresis. Since most human behaviour is goal-directed, the first is to employ patient-centred goal setting to engage and motivate patients to play an active part in their own rehabilitation. Goals should be meaningful for and achievable by the patient, and revised as necessary. The second foundation of success is to ensure detailed clinical assessment, using appropriate spasticity assessment scales to inform Botulinum toxin treatment plans -doses and muscles to be injected. Lastly, the use of guided self-rehabilitation programmes encourages an active role for patients in their treatment and maximises outcomes. This paper summarises proceedings from the Comprehensive Care of Patients with Spastic Paresis: A Long-Term Commitment symposium, at the International Society of Physical and Rehabilitation Medicine World Congress, 2015.
The full peer-reviewed, open-access article is available here:
Disclosure: Anthony Ward has been supported by Ipsen, Allergan, Merz and Medtronic for lecturing at educational events, participating in advisory boards and consultancy work. He has also received funding from Ipsen and Allergan to host educational workshops and seminars and received educational grants from Allergan to conduct clinical research trials. Wolfgang Jost is speaker and advisor for Allergan, IPSEN and Merz. Robert Jech served as a consultant and received research grant support from Abbvie, Allergan, Cardion, Ipsen and Medtronic. He received grants from the Czech Ministry of Education, the Czech Ministry of Health and the Charles University in Prague. Jean-Michel Gracies served as a consultant and received research grant support from Allergan, Ipsen and Merz.
touchNEUROLOGY (a division of Touch Medical Media) publishesEuropean Neurological Review, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of neurology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
For inquires please contact:
Carla Denaro - Managing Editor
Providing practical opinion to support best practice for busy healthcare professionals.